Population
Patients with chronic heart failure
Design
Review
Authors
Loading...
Highlights inflammation as therapeutic target in chronic HF; leaves open whether immunomodulatory therapies improve outcomes in trials.
Inflammation and immune activation are integral to the pathophysiology of chronic heart failure, representing potential therapeutic targets.
Carlos M. Orrego (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: